Product: Maxzide-25 (Triamterene and hydrochlorothiazide) tablets, USP, 37.5 mg/  25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-0464-01
Reason for recall: Superpotent Drug: Composite assay results obtained during routine stability testing were slightly above specification.
Recall initiated: 20180607
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated